Elevance Health, Inc. - 8-K Filing

Elevance Health reports Q2 operating revenue of $49.8B and raises FY 2026 adjusted EPS guidance to at least $27.00 (Items: 2.02 or Exhibit 99, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $ELV

Read the full article at SEC EDGAR

More Regulatory news